General
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce the expansion of its HIV genotyping menu of applications with the release of a new revolutionary assay, DeepChek® Assay HIV-1 Full PR/RT/INT Drug Resistance. The company keeps innovating …
ABL DIAGNOSTICS EXPANDS ITS HIV GENOTYPING ASSAYS OFFERING Read More »
ABL Diagnostics expands its commercial network and collaborations to offer unique Sanger & NGS based microbiology genotyping assays and software worldwide.
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the expansion of its network of exclusive distributors, able to offer the DeepChek® technology to laboratories willing to implement microbiology applications like HIV, SARS-CoV-2, Tuberculosis, Cytomegalovirus, Viral …
DeepChek ® HCV / HBV / HDV Assays & Software
DeepChek ® HCV / HBV / HDV Assays & Software Send Me More information
New kit Available !! Genotyping of the Full HIV-1 pol Gene with PR+RT+INT Regions in One Single PCR Reaction
New kit Available !! Genotyping of the Full HIV-1 pol Gene with PR+RT+INT Regions in One Single PCR Reaction Send Me More information
ABL Diagnostics: A partner of choice for your scientific projects
ABL Diagnostics: A partner of choice for your scientific projects APHP (Assistance Publique Hôpitaux de Paris) // France Epidemiological and Molecular evolution of the HIV-1 CRF94: Birth of CRF 132 ♦♦♦ CHU Caen-Normandie // France Interest of HIV-1 Next-Generation Sequencing in a diagnosis laboratory in France ♦♦♦ CHU Amiens-Picardie // France Whole Genome Sequencing of …
ABL Diagnostics: A partner of choice for your scientific projects Read More »
High-Resolution Bacterial identification through Whole 16s RNA Next Generation Sequencing
High-Resolution Bacterial identification through Whole 16s RNA Next Generation Sequencing
New Distribution Partnership with Biosistemi Grupa D.D.O. for 5 territories in the Balkans
New Distribution Partnership with Biosistemi Grupa D.D.O. for 5 territories in the Balkans We are pleased to announce that we entered into a distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software with Biosistemi Grupa d.o.o. for 5 territories:– Croatia– Montenegro– Kosovo– North Macedonia– Albania
Meet us at the 11th German-Austrian AIDS Congress (DÖAK 2023)
Meet us at the 11th German-Austrian AIDS Congress (DÖAK 2023) Sehen wir uns beim #DÖAK? Vom 23. bis 25. März 2023 sind wir beim 11. Deutsch-Österreichischen AIDS-Kongress in Bonn! Besuchen Sie uns am Stand und freuen Sie sich auf drei Kongresstage mit einem umfangreichen Programm auf dem höchsten Stand der wissenschaftlichen Forschung.Unter dem Motto „HIV und …
Meet us at the 11th German-Austrian AIDS Congress (DÖAK 2023) Read More »
New Scientific Publication: From Electrophoresis to Deep Sequencing: An Improved HIV-1 Drug Resistance Assessment Solution Using in Vitro Diagnostic (IVD Assays and Software
New Scientific Publication: From Capillary Electrophoresis to Deep Sequencing: An Improved HIV-1 Drug Resistance Assessment Solution Using In Vitro Diagnostic (IVD) Assays and Software We are pleased to share the release of our peer-reviewed article detailing the performances of the DeepChek® solution, reagents and software, which helps virologists and clinicians assessing HIV-1 Drug Resistance (HDR) …